Trial Profile
A trial of uteroglobin (CG-201) in patients with COPD
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 May 2015
Price :
$35
*
At a glance
- Drugs Uteroglobin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Therabron Therapeutics
- 19 May 2015 New trial record